The trial enrolled 281 participants with type 2 diabetes who were randomized to receive 0.5 mg, 4 mg, 8 mg, or 12 mg doses of retatrutide, 1.5 mg of dulaglutide, or placebo for 36 weeks
Annu Rev Nutr (2017) 37:15781
Sex- and gender-based pharmacological response to drugs
Although affinity-based screening technologies such as phage and yeast display enable the high-throughput screening of large combinatorial peptide libraries, they rely on the use of recombinant protein or membrane preparations and do not distinguish between agonists, inverse agonists and antagonists
The most recently approved type, tirzepatide [archived link], is called a dual agonist because it mimics the effects of two gut hormones, GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)
If youre interested in learning more about tirzepatide or how it can benefit you, we offer consultations with our medical professionals to discuss its potential for improving your health